Replies to post #214865 on Biotech Values

[biomaven0]

Interesting that AZN has an unused PRV - wonder if there is any chance they use it for roxadustat? Or more likely it goes for one of their oncology drugs like acalabrutinib.

Peter

[DewDiligence]

The raps.org list of PRVs is evidently out of date insofar as it does not include TEVA's purchase of a voucher for the Fremanezumab BLA.

[ghmm]

If someone wants to update/keep track...

RARE gets a PVR for their approval today
http://ir.ultragenyx.com/releasedetail.cfm?ReleaseID=1048901